Serum Institute to test if TB vaccine VPM1002 is effective against Covid-19
Serum Institute of India, the world ’s largest vaccine manufacturer, will soon start clinical trials in the country to test if tuberculosis vaccine VPM1002 is effective as a preventive and immunity booster vaccine against Covid-19.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Clinical Trials | COVID-19 | India Health | Pharmaceuticals | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines